I know there had been issues with Euthryox, especially when first launched in its new mannitol form.
However, I had not realised until just now that it is being withdrawn in France.
Below is an automatic translation (my French is very poor).
Is anyone able to explain the reasons for its withdrawal?
Support for substitution of levothyroxine therapy
The distribution of Euthyrox will remain available in France until the end of 2023.
In this context, you will find below recommendations for patients and healthcare professionals to accompany patients currently on EUTHYROX to a change of treatment to another levothyroxine-based specialty.
This accompanying language substitution document is a practical fact sheet for patients and healthcare professionals. It includes:
– Recommendations for patients taking EUTHYROX
– Recommendations for healthcare professionals
– List of levothyroxine medicines available in France (March 2023)
– The levothyroxine treatment follow-up book
pdf Distribution stop of EUTHYROX Subscription accompanying document (...) Downloading of the pdf (1.1 MB)
Link is to page in French - I used Firefox translation to get the above English. The PDF is also in French (of course).